Merit Medical Systems Operating Income 2010-2024 | MMSI

Merit Medical Systems operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Merit Medical Systems Annual Operating Income
(Millions of US $)
2023 $124
2022 $88
2021 $61
2020 $-2
2019 $15
2018 $59
2017 $33
2016 $35
2015 $38
2014 $40
2013 $28
2012 $30
2011 $33
2010 $17
2009 $33
Merit Medical Systems Quarterly Operating Income
(Millions of US $)
2024-03-31 $36
2023-12-31 $34
2023-09-30 $35
2023-06-30 $29
2023-03-31 $26
2022-12-31 $30
2022-09-30 $19
2022-06-30 $23
2022-03-31 $15
2021-12-31 $22
2021-09-30 $16
2021-06-30 $9
2021-03-31 $14
2020-12-31 $16
2020-09-30 $0
2020-06-30 $-19
2020-03-31 $1
2019-12-31 $-3
2019-09-30 $-3
2019-06-30 $12
2019-03-31 $10
2018-12-31 $14
2018-09-30 $21
2018-06-30 $15
2018-03-31 $9
2017-12-31 $13
2017-09-30 $1
2017-06-30 $13
2017-03-31 $6
2016-12-31 $13
2016-09-30 $3
2016-06-30 $12
2016-03-31 $8
2015-12-31 $8
2015-09-30 $9
2015-06-30 $12
2015-03-31 $9
2014-12-31 $14
2014-09-30 $12
2014-06-30 $7
2014-03-31 $6
2013-12-31 $11
2013-09-30 $8
2013-06-30 $7
2013-03-31 $2
2012-12-31 $4
2012-09-30 $9
2012-06-30 $8
2012-03-31 $8
2011-12-31 $6
2011-09-30 $7
2011-06-30 $11
2011-03-31 $10
2010-12-31 $6
2010-09-30 $-3
2010-06-30 $9
2010-03-31 $6
2009-12-31 $8
2009-09-30 $8
2009-06-30 $9
2009-03-31 $8
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.726B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.372B 21.99
Becton Dickinson (BDX) United States $67.549B 19.11
Cardinal Health (CAH) United States $25.353B 14.50
West Pharmaceutical Services (WST) United States $23.461B 42.05
Cooper (COO) United States $18.251B 26.92
Align Technology (ALGN) United States $18.233B 35.20
Labcorp (LH) United States $17.408B 14.98
Henry Schein (HSIC) United States $8.743B 15.55
DENTSPLY SIRONA (XRAY) United States $5.328B 13.80
Patterson (PDCO) United States $2.274B 10.99
CONMED (CNMD) United States $2.078B 18.85
STAAR Surgical (STAA) United States $2.026B 77.79
Atrion (ATRI) United States $0.803B 42.87
Lifevantage (LFVN) United States $0.085B 10.97
Pro-Dex (PDEX) United States $0.065B 32.67
Biolase (BIOL) United States $0.004B 0.00